Ludmilla Pinto Guiotti Cintra Abreu
Research Subjects
Ludmilla Pinto Guiotti Cintra Abreu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Graziella Anselmo Joanitti
Laboratory of Biocompounds and Nanobiotechnology, Darcy Ribeiro Campus, University of Brasília, Brasília 70910-900, Brazil
2 shared publications - Marcella Lemos Brettas Carneiro
Laboratory of Biocompounds and Nanobiotechnology, Darcy Ribeiro Campus, University of Brasília, Brasília 70910-900, Brazil
2 shared publications - Ronaldo Gonçalves Abreu2 shared publications
- Brenda de S. Moreno1 shared publication
- Gabriella de Oliveira Silva
Department of Nanoscience and Nanobiotechnology, Institute of Biology, University of Brasília, UnB, Brasília 70910-900, Brazil
1 shared publication - Gleide Célia Virgolino da Silva1 shared publication
Latest Publications
- Open Access
- 8 June 2026
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 36 (1)
Technological Prospection and Scientific Evidence of the Antimicrobial Activity of Bixa orellana: An Integrative Review
- 8 June 2026
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 36 (1)
Open AccessTechnological Prospection and Scientific Evidence of the Antimicrobial Activity of Bixa orellana: An Integrative Review
- Open Access
- 5 May 2026
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- p. 1-20
Revisão documental dos requisitos regulatórios internacionais para segurança de cosméticos com nanotecnologia
Introduction: Cosmetics formulated with nanotechnology (1.0 x 10–⁹ m) have great market potential due to their effectiveness and consumer satisfaction. Objective: To conduct a documentary review of international regulatory requirements related to the safety of cosmetics containing nanomaterials. Method: A systematic documentary analysis was performed using official websites of eight regulatory agencies: the United States, European Union, Canada, Japan, Australia, China, India, and South Korea. The research was structured using the PICOT acronym. Documents were screened based on inclusion and exclusion criteria and evaluated by peer reviewers. Data extraction was conducted using REDCap® software and organized into thematic frameworks. Results: Nine documents were included, with emphasis on those issued by the SCCS (EU), FDA (USA), ICCR, and MHLW (Japan). Regulatory convergence was observed in aspects such as the physicochemical characterization of nanomaterials (including size, morphology, purity, and stability) and the requirement for specific testing related to dermal irritation, inhalation toxicity, genotoxicity, and skin absorption. The analyzed documents highlight that nanomaterials may exhibit physicochemical properties, biological interactions, and toxicological effects distinct from the same ingredients on a conventional scale — with magnetic, optical, structural, electrical, and chemical differences that may impact product performance, safety, and efficacy. Conclusions: There is no international regulatory consensus on mandatory criteria for the useof nanomaterials in cosmetics. Agencies recommend multiple validated tests, applied to different product batches, and emphasize the importance of detailed physicochemical characterization as well as dose–response assessment as essential requirements. The experience of more established jurisdictions can support the advancement of the Brazilian regulatory framework in this emerging field.
- 5 May 2026
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- p. 1-20
Open AccessRevisão documental dos requisitos regulatórios internacionais para segurança de cosméticos com nanotecnologia
Introduction: Cosmetics formulated with nanotechnology (1.0 x 10–⁹ m) have great market potential due to their effectiveness and consumer satisfaction. Objective: To conduct a documentary review of international regulatory requirements related to the safety of cosmetics containing nanomaterials. Method: A systematic documentary analysis was performed using official websites of eight regulatory agencies: the United States, European Union, Canada, Japan, Australia, China, India, and South Korea. The research was structured using the PICOT acronym. Documents were screened based on inclusion and exclusion criteria and evaluated by peer reviewers. Data extraction was conducted using REDCap® software and organized into thematic frameworks. Results: Nine documents were included, with emphasis on those issued by the SCCS (EU), FDA (USA), ICCR, and MHLW (Japan). Regulatory convergence was observed in aspects such as the physicochemical characterization of nanomaterials (including size, morphology, purity, and stability) and the requirement for specific testing related to dermal irritation, inhalation toxicity, genotoxicity, and skin absorption. The analyzed documents highlight that nanomaterials may exhibit physicochemical properties, biological interactions, and toxicological effects distinct from the same ingredients on a conventional scale — with magnetic, optical, structural, electrical, and chemical differences that may impact product performance, safety, and efficacy. Conclusions: There is no international regulatory consensus on mandatory criteria for the useof nanomaterials in cosmetics. Agencies recommend multiple validated tests, applied to different product batches, and emphasize the importance of detailed physicochemical characterization as well as dose–response assessment as essential requirements. The experience of more established jurisdictions can support the advancement of the Brazilian regulatory framework in this emerging field.